Ancora Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$172K Buy
43,107
+5,238
+14% +$21K ﹤0.01% 744
2025
Q1
$120K Hold
37,869
﹤0.01% 806
2024
Q4
$203K Buy
37,869
+14,584
+63% +$78K ﹤0.01% 696
2024
Q3
$123K Buy
+23,285
New +$123K ﹤0.01% 771